As computational biology rises as a sector, we meet Duleek Ranatunga, founder of Pear Bio.

A scientist founder, Duleek has a background in pharmaceuticals, nano-engineering and medical statistics. Having always wanted to start a biotech company, Duleek founded Pear Bio to build solutions in precision oncology. Pear Bio uses computational biology techniques to ensure patients are getting the most effective chemotherapy combination for them, with the least side effects.

We discuss what computational biology is, how an organ on a chip works and how computer vision technology is used alongside the organ on a chip to create the Pear Bio solution. Duleek touches on building and maintaining relationships with clinicians in the UK and US, how he has approached fundraising and his investor funnel and the regulation required to work with human tissue samples and run a wet lab in London.

As a former oncological radiologist in the NHS, I have seen the oncology patient experience from inside of the hospital and I strongly believe in what Pear Bio are building which is why we invested in Pear Bio.